Cell Therapy Market by Therapy Type (Autologous and Allogenic), Therapeutic Type (Malignancies, Musculoskeletal disorders, Autoimmune disorders, Dermatology, and Others), Cell Type (Stem cell and Non-stem cell), and End User (Hospitals & Clinics and Academic & Research Institutes): Global Opportunity Analysis and Industry Forecast, 2019–2026

Pages: NA
Oct 2020 | 1635 Views
Author(s) : NA
Tables: NA
Charts: NA


Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Cell Therapy Market

Request Now !

Cell therapy is a technology, which relies on replacing diseased or dysfunctional cells with healthy functioning ones. Cells mainly used for such advanced therapies are stem cells, because of their ability to differentiate into the specific cells required for repairing damaged or defective tissues or cells. Moreover, cell therapy finds its application in the development of regenerative medicines, which is a multidisciplinary area aimed at maintenance, improvement, or restoration of cell, tissue, or organ function using methods mainly related to cell therapy. In addition, cells such as blood and bone marrow cells, mature, immature & solid tissue cells, adult stem cells, and embryonic stem cells are widely used in cell therapy procedures. Moreover, transplanted cells including induced pluripotent stem cells (iPSCs), embryonic stem cells (ESCs), neural stem cells (NSCs), and mesenchymal stem cells (MSCs) are divided broadly into two main groups including autologous cells and non-autologous cells.


The rise in adoption of human cells over animal cells for cell therapeutics research, technological advancements in field of cell therapy, and the increase in incidence of diseases such as cancer, cardiac abnormalities, and others are the key factors that drive the growth of the market. Furthermore, implementation of stringent government regulations regarding the use of cell therapy is anticipated to restrict the growth of the market. On the contrary, surge in number of regulations to promote stem cell therapy and increase in funds for research in developing countries are expected to offer lucrative opportunities to the market in near future. 

Recent advances in cell therapy include combining stem cell and tissue engineering methods to overcome the constraints of stem cells in human disease treatment and provide a fresh route to the regeneration of damaged tissues. A team of scientists from UCLA, the University of Washington and the Fred Hutchinson Cancer Research Center are developing an engineered hematopoietic stem and progenitor cells (HSPC) platform for the management of simian/human immunodeficiency virus (SHIV) infections. The team has created genetically modified blood-forming stem cells that express the ability to produce cells that can detect and destroy HIV-infected cells. They tested this novel platform on non-human primates, with satisfactory results. This is the first study to establish clinical relevance of HSPC-derived CAR T-cell therapy in animal models for HIV/AIDS Thermo Fisher Scientific launched an advanced data integrity laboratory management system for full regulatory compliance in 2018. Moreover, in 2018, Haifa in, Israel, Lonza opened her Collaborative Innovation. Further, in 2017, GE aid noninheritable straight line (UK) strengthened its cell medical care portfolio with a set of technologies for the cryopreservation of cellular materials.

The global cell therapy market is categorized on the basis of therapy type, therapeutic type, cell type, and region. On the basis of therapy type, the market is segregated into autologous and allogenic. Based on therapeutic type, it is classified into malignancies, musculoskeletal disorders, autoimmune disorders, dermatology, and others. On the basis of cell type, the market is segregated in to stem cell therapy and non-stem cell type. On basis of region, the market is studied across North America, Europe, Asia-Pacific, and LAMEA. 

The report provides a comprehensive analysis of the leading companies operating in the global cell therapy market are Kolon Tissue Gene, Inc., Osiris Therapeutics, Inc., JCR Pharmaceuticals Co. Ltd., NuVasive, Inc., Pharmicell Co Ltd., Vericel Corporation, Fibrocell Science Inc., Anterogen.co., Ltd., Stemedica Cell Technologies, Inc., Pharmicell Co., Ltd., and Medipost Co., Ltd.

Key Benefits for Stakeholders

  • The report provides an extensive analysis of the cell therapy market size, current market trends and future estimations of the market.
  • The cell therapy analysis is comprehensively covered with respect to the component, application, and region.
  • The cell therapy estimations in this report are based on high-end analysis of the key developments for 2018–2026.
  • Recent developments, key manufacturers, and top player positioning are listed in this report to analyze the competitive scenario of the cell therapy market.

Key Market Segments 

By Cell Type

  • Stem Cell 
    • Bone Marrow 
    • Blood
    • Umbilical Cord-Derived 
    • Adipose-Derived Stem Cell
    • Others 
  • Non-stem Cell 

By Therapy Type

  • Autologous
  • Allogeneic

By Therapeutic 

  • Malignancies 
  • Musculoskeletal Disorders 
  • Autoimmune Disorders
  • Dermatology 
  • Other

 By End User

  • Hospital & Clinics
  • Academic & Research Institutes

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • Rest of Asia-Pacific
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA


With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace

With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast

Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts

Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)

Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.


Start reading ,This title and over 12000 thousand more,available with Avenue Library,  T&C*

Reach out to us

Call us on
( U.S. - Canada toll free )
Int'l : +1-503-894-6022
( Europe )
+ 44-845-528-1300
Drop us an email at











Purchase Full Report of
Cell Therapy Market

  • Online Only
  • $3,456  $3,110
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Data Pack
  • $3,840  $3,456
  • Restricted to one authorized user
  • One print only
  • Available in
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Single User
  • $5,769  $5,192
  • Restricted to one authorized user
  • One print only
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Five Users
  • $6,450  $5,805
  • Limited to five authorized users
  • Print upto five copies
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Enterprise

  • $8,995  $8,096
  • Unlimited
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Library Membership
  • $ 699/mo
  • Published Content
  • Company Profiles
  • Newly Added Content Access
  • 10 PDF
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Start reading.
    This title and over 12,000+ are available on the Avenue Library.  T&C*.

    Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD


Why Allied Market Research?


Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction


On-demand customization of scope of the report to exactly meet your needs


Targeted market view to provide pertinent information and save time of readers


Featured Reports


Featured Readings


Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts